Suven Pharmaceuticals Ltd. was incorporated in the year 2018. Its today's share price is 471.65. Its current market capitalisation stands at Rs 12006.56 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10097.19 Cr and Total Income of Rs.10239.56 Cr. The company's management includes K Hanumantha Rao, Jerry Jeyasingh, JV Ramudu, Deepanwita Chattopadhyay, DG Prasad, Venkateswarlu Jasti, Venkateswarlu Jasti.
It is listed on the BSE with a BSE Code of 543064 , NSE with an NSE Symbol of SUVENPHAR and ISIN of INE03QK01018. It's Registered office is at #8-2-334 I, S D E Serene Chambers,6th Floor Road No. 5,Avenue 7, Banjara Hills Hyderabad-500034, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Karvy & Co, Tukaram & Co LLP